Local News SEngine Precision Medicine and Oncodesign Announce Collaboration Agreement for the Discovery of New Personalized Cancer Treatment for Aggressive and Untreatable Tumors Business Wire | February 11, 2022 SEngine Precision Medicine, a precision oncology company revolutionizing cancer therapies by pre-testing drugs on patient-derived…dcorriganFebruary 11, 2022 Read More
Local News How Does Leukemia Escape from Immunotherapy? Fred Hutch | February 10, 2022 When an experimental new cancer treatment shows promising results for many patients, these successes are…dcorriganFebruary 10, 2022 Read More
Local News The Paul G. Allen Frontiers Group Announces 23 New Allen Distinguished Investigators Allen Institute | February 10, 2022 Charting millions of unknown neurons in the octopus arm. Coaxing engineered mini-organs to grow their…dcorriganFebruary 10, 2022 Read More
Local News The Brain-Gut Connection: Dr. Person’s Unique Expertise Addresses Children with Chronic Gastrointestinal Issues Seattle Children's | February 8, 2022 Seattle Children’s is excited to welcome Dr. Hannibal Person to the Gastroenterology and Hepatology team.…dcorriganFebruary 8, 2022 Read More
Local News Coronavirus’ Distant Past Reveals Ancient Roots of Trait That Could Help Them Jump Species Fred Hutch | February 7, 2022 To infect our cells, SARS-CoV-2’s spike protein turns the key on the molecular doorway formed…dcorriganFebruary 7, 2022 Read More
Local News Seattle Children’s Welcomes Dr. Mignon Loh to Lead Cancer and Blood Disorders Care and Research Seattle Children's | February 4, 2022 Last year, if you had told Dr. Mignon Loh that she would soon become the leader of…dcorriganFebruary 4, 2022 Read More
Local News ADCETRIS® Combination Significantly Improves Overall Survival in Newly Diagnosed Patients with Advanced Hodgkin Lymphoma Seagen | February 4, 2022 Seagen announced that the Phase III ECHELON-1 clinical trial demonstrated a statistically significant improvement in…dcorriganFebruary 4, 2022 Read More
Local News Liver Institute Northwest Participating in RESPONSE, a Global Phase III Clinical Research Study Evaluating an Investigational Therapy for the Treatment of Primary Biliary Cholangitis (PBC) BioSpace | February 2, 2022 Liver Institute Northwest is enrolling participants into RESPONSE, a global phase 3 clinical research study…dcorriganFebruary 2, 2022 Read More
Local News Promising Young Scientists: Moez Dawood Brotman Baty Institute | January 31, 2022 Moez Dawood has numerous opportunities to explore saturation genome editing working alongside BBI’s Dr. Lea…dcorriganJanuary 31, 2022 Read More
Local News ‘Continuum of Expertise’ of International Researchers Examines Pediatric Epilepsy Brotman Baty Institute | January 31, 2022 About 470,000 children in the United States are diagnosed with epilepsy, or 6.3 out of…dcorriganJanuary 31, 2022 Read More